Abstract. Caldesmon is present in a high molecular mass form in smooth muscle and predominantly in a low molecular mass form in nonmuscle cells. Their biochemical properties are very similar. To examine whether these two forms of caldesmon behave differently in cultured cells, we microinjected fluorescently labeled smooth muscle and nonmuscle caldesmons into fibroblasts. Simultaneous injection of both caldesmons into the same cells has revealed that both high and low relative molecular mass caldesmons are quickly (within 10 min) and stably (over 3 d) incorporated into the same structures of micr0filaments including stress fibers and membrane ruffles, suggesting that nonmuscle cells do not distinguish nonmuscle caldesmon from smooth muscle caldesmon. The effect of calmodulin on the incorporation of caldesmon has been examined by coinjection of caldesmon with calmodulin. We have found that calmodulin retards the incorporation of caldesmon into stress fibers for a short period (10 min) but not for a longer incubation (30 min). The behavior of caldesmon in developing muscle cells was also examined because we previously observed that caldesmon disappears during myogenesis (Yamashiro, S., R. Ishikawa, and F. Matsumura. 1988.
mass form in smooth muscle and predominantly in a low molecular mass form in nonmuscle cells. Their biochemical properties are very similar. To examine whether these two forms of caldesmon behave differently in cultured cells, we microinjected fluorescently labeled smooth muscle and nonmuscle caldesmons into fibroblasts. Simultaneous injection of both caldesmons into the same cells has revealed that both high and low relative molecular mass caldesmons are quickly (within 10 min) and stably (over 3 d) incorporated into the same structures of micr0filaments including stress fibers and membrane ruffles, suggesting that nonmuscle cells do not distinguish nonmuscle caldesmon from smooth muscle caldesmon. The effect of calmodulin on the incorporation of caldesmon has been examined by coinjection of caldesmon with calmodulin. We have found that calmodulin retards the incorporation of caldesmon into stress fibers for a short period (10 min) but not for a longer incubation (30 min) . The behavior of caldesmon in developing muscle cells was also examined because we previously observed that caldesmon disappears during myogenesis (Yamashiro, S., R. Ishikawa, and F. Protoplasma Suppl. 2: 9-21) . We have found that, in contrast to its stable incorporation into stress fibers of fibroblasts, caldesmon is unable to be incorporated into thin filament structure (I-band) of differentiated muscle.
C ALDESMON, first identified in smooth muscle, is a unique actin binding protein whose binding to actin is regulated by Ca2+/calmodulin (24) . A wide variety of nonmuscle cells have been reported to contain caldesmon, which shows lower molecular masses on SDS gels than does smooth muscle caldesmon (ranging from 70,000 to 80,000 vs. 140,000 D of smooth muscle caldesmon) (3, 8, 16, 29) . In cultured cells, nonmuscle caldesmons are found to be colocalized with actin, suggesting their involvement in microfilament organization and the regulation of cell motility. Both muscle and nonmuscle ealdesmon have similar properties including a rodlike molecular shape, heat stability, calmodulin regulation of actin binding, self-association through disulfide bonds, periodic localization along actin filaments, and stimulation of actin binding of tropomyosin (1-3, 8, 16, 24, 28, 29) . Bryan . While NH2-terminal (200 amino acids) and COOH-terminal (324 amino acids) regions are exactly the same in smooth muscle and nonmuscle caldesmons, nonmuscle caldesmon is missing 232 amino acids from the central region of smooth muscle caldesmon, including a characteristic domain with an eightfold repeat of a 13 amino acid sequence. The sequence data together with the studies of domain mapping by others (11, 15, 22, 25, 30) have placed the actin-and calmodulin-binding domain at the COOH-terminal end of the molecule and the myosin binding domain at the NH2 terminus. These studies have also revealed that caldesmons have much lower molecular masses than predicted by SDS-PAGE. The calculated molecular masses for chicken smooth muscle and nonmuscle caldesmons are 87,000 and 60,000 D, respectively.
The differences in biological functions of these caldesmons caused by the structural difference are not clear. The wide occurrence of the nonmuscle type of caldesmon in nonmuscle tissue and culture cells suggests that nonmuscle caldesmon may function in a way different from smooth muscle caldesmon. In this study, we have microinjected fluorescently labeled muscle and nonmuscle caldesmons into fibroblasts in order to see whether these two types of caldesmons behave differently in vivo. We have found that both high and low relative molecular mass caldesmons are incorporated into the same structures of microfilaments despite the structural difference. In addition, because we previously observed that caldesmon disappears during myogenesis (28), we have examined whether caldesmon is stably incorporated into actin structures of muscle cells. We have observed that, unlike fibroblasts, muscle cells actively exclude caldesmon from thin filament structure.
Materials and Methods

Protein Purification
Smooth muscle caldesmon was purified from frozen bovine aorta and chicken gizzard by the method of Bretscher (1) with slight modification as described (28) . Nonmuscle caldesmon was purified from fresh bovine liver by the method described previously (28) except that the last hydxoxylapatite column was omitted. COOH-terminal 40-kD fragments of chick gizzard smooth muscle caldesmon were prepared according to Fujii et al. (11) . Skeletal muscle actin was purified as described previously (18) . Alphaactinin was purified from chicken gizzard as described by Feramisco and Burridge (9) , and conjugated with FITC as described (23) .
Conjugation of Caidesmon with Fluorescent Dyes
Caldesmons from smooth muscle and nonmuscle cells were conjugated with tetramethylrhodamine-5-(and-6)-iodoacetamide (TMRIA) 1 or 5-iodoacetamidofluorescein OAF) (Molecular Probes Inc., Eugene, OR). Caldesmons are known to form oligomers through disulfide bonds when reducing agents are removed by dialysis. Because this will eliminate free cysteine residues from caldesmon for conjugation with the dyes, we have conjugated caldesmons with excess amounts of the dyes over the concentration of reducing agents present in caldesmon preparation. In fact we found that caldesmun was conjugated very poorly with the dyes when reducing agents were removed by dialysis.
Caldesmons (1-5 mg/ml) in 20 mM Tris-acetate buffer containing 0.1 M KC1 and 0.2 mM DTT were incubated with 0.5-1 mM of either TMRIA or IAF on ice for 4 h. The reaction was terminated by the addition of 2-mereaptoethanol to a final concentration of 50 raM. The free dye was removed by using Bio-Beads SM-2 (Bio-Rad Laboratories, Richmond, CA) as described (19) . For purification of caldesmon with actin binding ability, dye-conjugated caldesmon (final concentration, 0.5 mg/mi) was incubated at room temperature for 1 h with 1 mg/ml of actin in 20 mM imidazole buffer ofpH 7.0 containing 0.1 M KC1 and 1 mM DTT. After centrifugation with an Alrfuge (26 psi x 20 min; Beckman Instruments, Inc., Palo Alto, CA), the pellets were suspended in 50 ~ of 20 mM potassium phosphate or 20 mM imidazole buffer of pH 7.0 containing 0.1 M KC1 and 1 mM DTT. After heat treatment at 100°C for 10 rain, dye-conjugated caldesmons (1 mg/mi) were recovered in the supernatants by centrifugation with an Airfuge, and used for microinjection or actin binding assay.
The dye/protein ratios of TMRIA-conjugated caldesmons were estimated based on a molar extinction coefficient of 47,000 at 552 nm (7), and assuming that molecular masses of nonmuscle and smooth muscle caldesmon were 60,000 and 87,000 D, respectively (4; Bryan, J., R. Lee 
Cell Culture
REP-52 cells (an established rat embryo cell line) and gerbil fibroma cells (CCL-146; American Type Culture Collection, Rockville, MD) were maintained in DME containing 10% newborn calf serum in an atmosphere of 5 % CO2 and 95 % air at 37°C. Chick embryo myoblasts were prepared from the thigh muscle of an ll-d chick and cultured in DME supplemented with 15% horse serum and 2% of chick embryo extracts. They began to fuse at 2 d and differentiated into myotubes with sarcomere structures at ,'~10 d. Chick embr3~ fibroblasts were also maintained in DME supplemented with 15% horse serum and 2% of chick embryo extracts.
Microinjection
The technique of Graessmann and Graessmann (12) was used for microinjection of the fluorescently labeled proteins into cells. Needles were made with a Narishige needle puller and injection was performed with a Narishige micromanipuiator (Narishige, Tokyo, Japan) attached to an Olympus in-
Abbreviations used in this paper: IAF, 5-iodoacetamidofluorescein;
TMRIA, tetramethylrhodamine-5-(and-6)-iodoacetamide.
verted microscope (IMT-2). After injection, cells were incubated in an CO2 incubator, fixed at a certain time (usually at 1611) with 3.7% formaldehyde in PBS, washed with PBS, and mounted on slides with gelvatol. Fluorescence was observed with an Olympus BH-2 microscope equipped for epifluorescence and phase contrast. Fluorescent photographs were taken using Kodak T-Max P3200 films and developed with T-Max developer for an ASA rating of 3,200. Phase-contrast photographs were taken with Kodak Technical Pan films and developed with Rodinal developer. When the incorporation of fluorescent caldesmon in living cells was examined, or when fluorescence was at a low level, images were taken with a SIT video camera (Dage-MTI, Inc.), processed with an Argus 10 image processor (Phototonic, Hamamatsu City, Japan), and subsequently photographed from the monitor with 35 mm Technical Pan film (developed with Technidol liquid developer). 
Binding of Dye-conjugated Caidesmon on
Other Procedures
Immunoduorescence was performed as described (27) . Protein concentrations were determined by the BCA protein assay reagent (Pierce Chemical Co., Rockford, IL) using bovine serum albumin as a standard. Protein concentrations of dye-conjugated caldesmons were determined as follows. Dyeconjugated caldesmon, together with intact ealdesmons with known concentrations were run on SDS gels, stained with Coomassie blue, and quantified by densitometry as described (26) . SDS-PAGE was performed as described (29) . Actin binding activity of caldesmon was assayed as described before (29) .
Results
Actin Binding Properties of Dye-conjugated Smooth Muscle and Nonmuscle Caldesmons
For the conjugation of smooth muscle and nonmuscle caldesmons, we initially tested two kinds of fluorescent dyes that are different in the reactivities. One is iodoacetamides, which reacts with cysteine residues of protein. The other is isothiocyanates, which reacts with e-amino residues. Although caldesmons conjugated with either dye were observed to be incorporated into stress fibers when injected, caldesmon conjugated with the latter dyes showed much higher background and more diffuse staining than did caldesmon conjugated with the former dyes. We have thus chosen fluorescein or rhodamine iodoacetamide for this study. Dye-conjugated caldesmons were further purified by using F-actin binding ability of caldesmon as described ill Materials and Methods. The molar ratios of dye (TMRIA) to the caldesmons were estimated as 0.75 for bovine aorta smooth muscle caldesmon, 0.5 for chicken gizzard caldesmon, and 0.35 for bovine liver nonmuscle caldesmon.
We have examined actin binding properties of purified dye-conjngated bovine smooth muscle and nonmuscle caldesmons. As Fig. 1, A and B show, dye-conjugated caldesmons appear to show actin binding ability similar to that of intact proteins. Furthermore, actin binding of dye-conjugated smooth muscle and nonmuscle caldesmon is regulated by Ca 2÷/calmodulin in the same way as that of intact molecule. Chick gizzard caldesmon labeled with the same dye also shows actin binding properties similar to those of intact proteins (data not shown).
To further examine the actin binding property of dyeconjugated caldesmons, we have examined their binding to a permeabilized cell model with or without calmodulin. When calmodulin is absent, TMRIA-conjugated liver caldesmons bind to stress fibers either in the presence or absence of Ca 2+ (Fig. 2 A) . When calmodulin is present, the binding is regulated by Ca 2+/calnlOduiin as is the binding of dye-conjugated caldesmons to actin (Fig. 1) . In the presence of Ca 2÷, caldesmon shows very weak binding to stress fibers (Fig. 2 B) , while caldesmon binds well to a cell model in the absence of Ca 2+. Similar results were obtained with dye-conjugated smooth muscle caldesmon (data not shown).
Microinjection of Nonmuscle and Smooth Muscle Caldesmons into Fibroblasts
We then microinjected them into rat fibroblasts (REF 52 cells) to see their incorporation into the microfilament structures. As Fig. 3 shows, both bovine muscle and nonmuscle caldesmons are incorporated into stress fibers periodically (,4 and C). These patterns of the incorporation correspond to the localization of endogenous caldesmon revealed by immunofluorescence (Fig. 3 G) .
The injected caldesmons, regardless whether they come from nonmuscle or smooth muscle cells, are quickly and stably incorporated into stress fiber structures. These caldesmons are observed in stress fibers within 10 min after injection and are stably present for over 3 d although the intensity of fluorescence is decreased by dilution due to cell division.
We have also examined incorporation of caldesmon into membrane ruffles because caldesmon is known to be localized in membrane ruffles as well. To this end, we have microinjected caldesmon into chick embryo fibroblasts, which have more membrane ruffle structures than REF 52 cells. As Fig. 3 , E and F show, both bovine smooth muscle and nonmuscle caldesmons are incorporated into membrane ruffles as well as stress fibers. Similar incorporation to microfilament structures is also seen with injection of dyeconjugated chick gizzard caldesmon (data not shown).
We have observed distribution of injected caldesmon in living cells because Cooper et al. (6) have shown that fixation changes the distribution of microinjected gelsolin from diffuse to fibrillar patterns. As Fig. 4 shows, injected caldesmon was observed to be incorporated into stress fibers of living REF 52 cells (Fig. 4 A) , as well as membrane ruffles of living gerbil fibroma cells (Fig. 4 B) . Although the background is somewhat higher than that of fixed images, the incorporation of caldesmon in living cells appears very similar to the pattern of distribution shown by fixed cells.
Simultaneous Injection of Smooth and Nonmuscle Caldesmons into the Same Cells
Because the incorporation of smooth muscle caldesmon appears to be similar to that of nonmuscle caldesmon, we asked whether these two types of caldesmons are incorporated into the same structures of microfilaments. To distinguish smooth and nonmuscle caldesmon in the same cells, these two caldesmons were separately labeled with two different dyes (TMRIA and IAF), mixed to make a equal molar concentration (6/zM of smooth muscle and 6/zM of nonmuscle caldesmon), and injected into REF 52 or gerbil fibroma cells. As  Fig. 5, A, B , and C show, coinjected smooth muscle aao nonmuscle caldesmons show indistinguishable incorporation into stress fibers in the same REF 52 cells. The injection into gerbil fibroma cells (Fig. 5, D , E, and F) has clearly demonstrated that two species of caldesmon are equally distributed into two different microfilament structures, i.e., stress fibers and membrane ruffles. The fluorescent structures derived from smooth muscle caldesmon are found to correspond exactly to those derived from nonmuscle caldesmon.
To examine whether these two species of caldesmon compete each other in the incorporation into stress fibers, we microinjected 5 ~M (final concentration) of dye-conjugated bovine liver or chick smooth muscle caldesmon that had been mixed with varying concentrations (0-80 ~M) of either smooth muscle or liver unconjugated caldesmon. If, for example, smooth muscle caldesmon bind to stress fibers better than nonmuscle species, smooth muscle unconjugated caldesmon would compete fluorescent nonmnscle caldesmon out of stress fibers more effectively than nonmuscle unconjugated caldesmon does. We have found, however, that both species of caldesmon give the same effects; fluorescently conjugated liver caldesmon on stress fibers was equally diluted out as the concentrations of unconjugated caldes- taken with a SIT video camera as described in Materials and Methods. Note that both species of caldesmon equally decrease the fluorescence of bovine liver caldesmon incorporated into stress fibers, suggesting that cells do not distinguish between these two species of caldesmon. mon, regardless of species of caldesmon, were increased (Fig. 6) . These results suggest that nonmuscle and smooth muscle caldesmons appear to have an indistinguishable ability of the incorporation into stress fibers.
Injection of COOH-Terminal Fragments into Fibroblasts
Because both high and low relative molecular mass caldesmons are incorporated into the same structures of stress fibers despite the structural differences, we asked whether even small fragments of caldesmon with the functional actin binding domain are incorporated into stress fibers. Studies on domain structure of gizzard caldesmon have revealed that the actin binding and calmodulin binding domain is localized in COOH-terminal 40-kD fragments (11, 15, 22, 25, 30) . The protein sequence derived from eDNA cloning has revealed that one of the two cysteine residues of chick gizzard caldesmon are localized in the middle of the COOH-terminal fragments, allowing us to conjugate COOH-terminal fragments with TMRIA to see their incorporation. Dye-conjugated COOH-terminal fragments was also purified by cosedimentation with F-actin and injected into REF-52 cells. As Fig. 7 shows, COOH-terminal fragments are incorporated into stress fibers. Their incorporation in some places appears periodic as seen in the case of the injection of intact molecule.
Effects of Coinjection with Calmodulin
Effects of coinjection of caldesmon with Ca2+/calmodulin have been examined because actin binding of caidesmon is inhibited by Ca2+/calmodulin in vitro. To ensure the complex formation, dye-conjugated caldesmon (1 mg/ml) is incubated with 20 times molar excess (final concentration, 4 mg/ml) of calmodulin over caldesmon in the presence of 0.1 mM of CaCl:~and then injected into fibroblasts. As a control, caldesmon in 0.1 mM CaC12 but without calmodulin was injected. As Fig. 8, A and B show, coinjection with calmodulin retards the incorporation of caldesmon for a short time after injection. While control caldesmon without calmodulin (Fig. 8 B) is quickly incorporated into stress fibers within 10 min, most of caldesmon complexed with calmodulin (A) is diffusely present at the same time. The effect of calmodulin, however, disappears as the cells are incubated for longer than 30 rain. AS Fig. 8, C and D show, the incorporation of caldesmon coinjected with calmodulin (C) appears indistinguishable from that (D) of control.
Microinjection of Dye-conjugated Caldesmon into Muscle Cells
Our results indicate that caldesmon is a stable protein that remains bound to stress fibers over 3 d. On the other hand, we previously observed that nonmuscle caldesmon present in myoblasts disappears during fusion of myoblasts into myotubes (28) . We have thus examined whether smooth muscle or nonmuscle caldesmon is stably incorporated into actin microfilaments of developing muscle cells. Chick myoblasts were used for this purpose because these cells are easily differentiated into myotubes with sarcomere structures.
AS Fig. 9 , A and B show, caldesmon is unexpectedly found in A-bands but not in I-bands when it is injected into myotubes with sarcomere structures. This A-band incorporation (Fig. 9 C) is quite unstable and quickly disappears after a 16-h incubation (Fig. 9 E) . As a control, we have coinjected FITC-labeled tx-actinin into myotubes. As Fig. 9 , D and F show, ~actinin remains stably incorporated into Z-bands after 16 h. Similar results were obtained with the injection of smooth muscle caldesmon.
We have also injected caldesmon into myotubes that have not developed sarcomere structures. While caldesmon is found to be incorporated into microfilament bundles of myotubeS, the incorporation is again very unstable and disappears after a 16-h incubation (data not shown). These results suggest that, unlike fibroblasts, muscle cells actively exclude caldesmon from their actomyosin system.
Discussion
Nonmuscle Cells Do Not Distinguish Smooth Muscle and Nonmuscle Caldesmons
Smooth muscle caldesmon has additional central regions (27 kD) including a repeated domain while both nonmuscle and smooth muscle share NH2-terminal and COOH-terminal portions (4; Bryan, J., R. lee, S. J. Chang, and W. G. Lira. (Fig. 5) . The incorporation is apparentiy normal because it is indistinguishable from the localization of endogenous caldesmon (Fig. 3) . Furthermore, one species of caldesmon does not appear to compete the other out from stress fibers (Fig. 6 ). These results indicate that nonmuscle cells do not distinguish smooth muscle and nonmuscle caldesmons in terms of the incorporation into microfilaments. This notion is extended by the observation that a 40-kD actin and calmodulin binding proteolytic fragment is incorporated into stress fibers (Fig. 7) , suggesting that caldesmon incorporation needs only the actin-binding domain.
The introduction of smooth muscle caldesmon at a concentration comparable to the endogenous nonmuscle caldesmon does not appear to affect the organization of the microfilament system in fibroblasts. The highest concentration of smooth muscle caldesmon used for microinjection was 7 mg/ml. Microinjection usually introduces ,~,10 -t3 liter of solution into most fibroblasts (10) , which allows for the introduction of 4 × 10~ molecules per cell. Because ,~,0.03-0.08 % of the cellular protein is nonmuscle caldesmon (Ishikawa, R., and F. Matsumura, unpublished results), each cell contains '~2-6 × l06 molecules of caldesmon per The incorporation of caldesmon into developing muscle cells is very different from its incorporation into fibroblasts. When caldesmon is injected into myotubes with sarcomere structures, it is unexpectedly incorporated into the A-band, rather than the I-band, just for a short time. On overnight incubation, caldesmon is excluded from muscle cells. This A-band incorporation is probably due to the direct binding of caldesmon to myosin (13, 14) . These results are consistent with our previous observation that caldesmon disappears during fusion of myoblasts into myotubes but inconsistent with the report describing the presence of caldesmon in muscle cells (21) . Further, these results suggest that thin filaments of developing muscle cells have some structure that inhibits the binding of caldesmon. At present, we do not know what inhibits the acfin bindifig of caldesmon. One candidate for such structure may be troponin/tropomyosin system. However, we could not observe competitive inhibition of actin binding of caldesmon by tropomyosin/troponin in vitro (data not shown).
Effects of the Modification of Cysteine Residues on the Actin Binding
The modification of thiol residues of chicken smooth muscle caldesmon or its 40-kD chymotryptic fragments with either fluorescein or rhodamin iodoacetamides does not appear to alter actin-binding properties of these proteins, nor to change regulation of their actin binding by Ca2+/calmodulin. This is consistent with the domain structure of the 40-kD fragments. According to the domain mapping studies (4, 22), a cysteine residue is located appro "xnnately at the middle of the 40-kD fragments, and COOH-terminal 25-kD fragments generated by chemical cleavage at the cysteine residue still retain actin and calmodulin binding properties.
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